Analyze Diet
Prostaglandins & other lipid mediators2019; 142; 1-8; doi: 10.1016/j.prostaglandins.2019.02.007

Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1β-stimulated equine synoviocytes.

Abstract: Omega-3 fatty acid (n-3 PUFA) supplementation may have beneficial effects in certain chronic diseases, potentially including osteoarthritis. Favorable effects are attributed, in part, to downstream pro-resolving oxylipid metabolites. We investigated the role of n-3 PUFA and docosahexaenoic acid (DHA)-derived oxylipids (docosanoids) on equine synoviocyte metabolism. We hypothesized that n-3 PUFA and selected docosanoids would modulate inflammatory mediator gene expression by recombinant equine (re)IL-1β-stimulated synovial fibroblasts. Synoviocyte monolayer cultures were prepared from grossly normal equine carpal synovium. Cellular incorporation of eicosapentaenoic acid (EPA) and DHA was determined using LC-MS and docosanoid biosynthesis by LC-MS-MS. The influence of n-3 PUFA and docosanoids on osteoarthritis marker gene expression was determined by quantitative real time polymerase chain reaction (qPCR). Synoviocytes incorporated EPA and DHA in significant amounts and DHA treatment augmented the synthesis of several docosanoids. Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1β stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1β, IL-6 and COX-2. The docosanoids resolvin D1 and D2, maresin 1 and protectin DX, alone and in combination, abrogated ADAMTS4, MMP-1, MMP-13, and IL-6 gene expression in reIL-1β-stimulated synoviocytes. Similarly, both resolvins and maresin 1 stifled COX-2 expression. Our results demonstrate that synoviocytes readily incorporate n-3 PUFA. DHA incorporation was sufficient for biosynthesis of significant concentrations of several docosanoids which modulated the synovial inflammatory response in vitro. These data indicate n-3 PUFA supplementation may prove useful in the prevention or treatment of osteoarthritis.
Publication Date: 2019-03-02 PubMed ID: 30836143DOI: 10.1016/j.prostaglandins.2019.02.007Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the effects of Omega-3 fatty acids and certain derivatives on the inflammation in joint cells of horses. The results suggest that these compounds may have a potential role in preventing or treating osteoarthritis.

Objective of the Study

  • The study aimed to explore the role of Omega-3 fatty acids and docosahexaenoic acid (DHA)-derived oxylipids (docosanoids) on the metabolism of synoviocytes, the cells that line the inner part of joint cavities.
  • It was hypothesized that these compounds would influence the gene expression of inflammatory mediators in interleukin1β-stimulated synoviocytes, thus potentially indicating their effect on osteoarthritis, a chronic disease characterized by joint inflammation.

Methodology and Results

  • Synoviocyte monolayer cultures were created using equine carpal synovium, a tissue found within equine joints.
  • The incorporation of eicosapentaenoic acid (EPA) and DHA into cells was determined using liquid chromatography–mass spectrometry (LC-MS) and the synthesis of docosanoids was examined using liquid chromatography–tandem mass spectrometry (LC-MS-MS).
  • It was determined that treatment with DHA increased the synthesis of several types of docosanoids.
  • Molecular analysis using quantitative real-time polymerase chain reaction (qPCR) indicated that pre-treatment with EPA or DHA caused a significant reduction in the expression of key inflammatory mediators (ADAMTS4, MMP-1, MMP-13, IL-1β, IL-6 and COX-2).
  • Furthermore, the docosanoids resolvin D1 and D2, maresin 1 and protectin DX single or combined also effectively reduced the gene expression of these inflammatory mediators in IL-1β-stimulated synoviocytes.
  • It was also found that n-3 PUFA were efficiently incorporated into synoviocytes, suggesting that cells could readily uptake these compounds.

Conclusion and Implications

  • The results of the study indicate that Omega-3 fatty acids and the DHA-derived docosanoids had a significant dampening effect on the expression of inflammatory mediators in synoviocytes, pointing at their potential anti-inflammatory role in joint health.
  • This suggests that supplementation with Omega-3 fatty acids might have potential utility in the prevention or management of osteoarthritis; however, further research is needed in vivo to confirm these in vitro findings.

Cite This Article

APA
Caron JP, Gandy JC, Brown JL, Sordillo LM. (2019). Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1β-stimulated equine synoviocytes. Prostaglandins Other Lipid Mediat, 142, 1-8. https://doi.org/10.1016/j.prostaglandins.2019.02.007

Publication

ISSN: 1098-8823
NlmUniqueID: 9808648
Country: United States
Language: English
Volume: 142
Pages: 1-8

Researcher Affiliations

Caron, John P
  • Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI, 48823-1314, United States. Electronic address: caron@cvm.msu.edu.
Gandy, Jeffrey C
  • Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI, 48823-1314, United States.
Brown, Jennifer L
  • Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI, 48823-1314, United States.
Sordillo, Lorraine M
  • Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI, 48823-1314, United States.

MeSH Terms

  • Animals
  • Cytokines / metabolism
  • Docosahexaenoic Acids / metabolism
  • Docosahexaenoic Acids / pharmacology
  • Docosahexaenoic Acids / therapeutic use
  • Eicosapentaenoic Acid / metabolism
  • Eicosapentaenoic Acid / pharmacology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Gene Expression Regulation / drug effects
  • Horses
  • Inflammation / metabolism
  • Inflammation / pathology
  • Interleukin-1beta / pharmacology
  • Osteoarthritis / drug therapy
  • Osteoarthritis / metabolism
  • Osteoarthritis / pathology
  • Recombinant Proteins / pharmacology
  • Synoviocytes / drug effects
  • Synoviocytes / metabolism
  • Synoviocytes / pathology

Citations

This article has been cited 17 times.
  1. Korac L, St George L, MacNicol J, McCrae P, Jung L, Golestani N, Karrow N, Cánovas A, Pearson W. Functional and biochemical inflammatory responses to low-dose intra-articular recombinant equine IL-1β: a pilot study. Front Vet Sci 2025;12:1746738.
    doi: 10.3389/fvets.2025.1746738pubmed: 41624292google scholar: lookup
  2. Mao H, Lu G, Zheng L, Zhuang M, Liang L, Zhou S, Li J, Sun X, Liu Y, Ma M, Hu J, Yu J, Zhu L. The research progress and potential applications of n-3 fatty acids in orthopaedics: a narrative review. Br J Nutr 2025 Jul 14;134(1):57-69.
    doi: 10.1017/S0007114525103875pubmed: 40637132google scholar: lookup
  3. Jerab D, Blangero F, da Costa PCT, de Brito Alves JL, Kefi R, Jamoussi H, Morio B, Eljaafari A. Beneficial Effects of Omega-3 Fatty Acids on Obesity and Related Metabolic and Chronic Inflammatory Diseases. Nutrients 2025 Apr 3;17(7).
    doi: 10.3390/nu17071253pubmed: 40219010google scholar: lookup
  4. Villagrán-Andrade KM, Núñez-Carro C, Blanco FJ, de Andrés MC. Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis. Pharmaceuticals (Basel) 2024 Aug 30;17(9).
    doi: 10.3390/ph17091148pubmed: 39338311google scholar: lookup
  5. Lin RT, Osipov B, Steffen D, Chamberlin M, Pathak SJ, Christiansen BA, Paulussen KJM, Baar K. Saturated fatty acids negatively affect musculoskeletal tissues in vitro and in vivo. Matrix Biol Plus 2024 Aug;23:100153.
    doi: 10.1016/j.mbplus.2024.100153pubmed: 38882396google scholar: lookup
  6. Burron S, Richards T, Krebs G, Trevizan L, Rankovic A, Hartwig S, Pearson W, Ma DWL, Shoveller AK. The balance of n-6 and n-3 fatty acids in canine, feline, and equine nutrition: exploring sources and the significance of alpha-linolenic acid. J Anim Sci 2024 Jan 3;102.
    doi: 10.1093/jas/skae143pubmed: 38776363google scholar: lookup
  7. Everett JB, Menarim BC, Barrett SH, Bogers SH, Byron CR, Pleasant RS, Werre SR, Dahlgren LA. Intra-articular bone marrow mononuclear cell therapy improves lameness from naturally occurring equine osteoarthritis. Front Vet Sci 2023;10:1256284.
    doi: 10.3389/fvets.2023.1256284pubmed: 37876630google scholar: lookup
  8. Liu WC, Yang YH, Wang YC, Chang WM, Wang CW. Maresin: Macrophage Mediator for Resolving Inflammation and Bridging Tissue Regeneration-A System-Based Preclinical Systematic Review. Int J Mol Sci 2023 Jul 2;24(13).
    doi: 10.3390/ijms241311012pubmed: 37446190google scholar: lookup
  9. Gambari L, Cellamare A, Grassi F, Grigolo B, Panciera A, Ruffilli A, Faldini C, Desando G. Targeting the Inflammatory Hallmarks of Obesity-Associated Osteoarthritis: Towards Nutraceutical-Oriented Preventive and Complementary Therapeutic Strategies Based on n-3 Polyunsaturated Fatty Acids. Int J Mol Sci 2023 May 26;24(11).
    doi: 10.3390/ijms24119340pubmed: 37298291google scholar: lookup
  10. Mustonen AM, Tollis S, Käkelä R, Sihvo SP, Palosaari S, Pohjanen VM, Yli-Hallila A, Lehenkari P, Nieminen P. Increased n-6 Polyunsaturated Fatty Acids Indicate Pro- and Anti-Inflammatory Lipid Modifications in Synovial Membranes with Rheumatoid Arthritis. Inflammation 2023 Aug;46(4):1396-1413.
    doi: 10.1007/s10753-023-01816-3pubmed: 37140681google scholar: lookup
  11. Mustonen AM, Lehmonen N, Paakkonen T, Raekallio M, Käkelä R, Niemelä T, Mykkänen A, Sihvo SP, Nieminen P. Equine osteoarthritis modifies fatty acid signatures in synovial fluid and its extracellular vesicles. Arthritis Res Ther 2023 Mar 9;25(1):39.
    doi: 10.1186/s13075-023-02998-9pubmed: 36895037google scholar: lookup
  12. Pezzanite LM, Chow L, Griffenhagen GM, Bass L, Goodrich LR, Impastato R, Dow S. Distinct differences in immunological properties of equine orthobiologics revealed by functional and transcriptomic analysis using an activated macrophage readout system. Front Vet Sci 2023;10:1109473.
    doi: 10.3389/fvets.2023.1109473pubmed: 36876001google scholar: lookup
  13. Jiang H, Pu Y, Li ZH, Liu W, Deng Y, Liang R, Zhang XM, Zuo HD. Adiponectin, May Be a Potential Protective Factor for Obesity-Related Osteoarthritis. Diabetes Metab Syndr Obes 2022;15:1305-1319.
    doi: 10.2147/DMSO.S359330pubmed: 35510046google scholar: lookup
  14. Menarim BC, MacLeod JN, Dahlgren LA. Bone marrow mononuclear cells for joint therapy: The role of macrophages in inflammation resolution and tissue repair. World J Stem Cells 2021 Jul 26;13(7):825-840.
    doi: 10.4252/wjsc.v13.i7.825pubmed: 34367479google scholar: lookup
  15. Mustonen AM, Käkelä R, Joukainen A, Lehenkari P, Jaroma A, Kääriäinen T, Kröger H, Paakkonen T, Sihvo SP, Nieminen P. Synovial Fluid Fatty Acid Profiles Are Differently Altered by Inflammatory Joint Pathologies in the Shoulder and Knee Joints. Biology (Basel) 2021 May 4;10(5).
    doi: 10.3390/biology10050401pubmed: 34064447google scholar: lookup
  16. Mustonen AM, Nieminen P. Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis-a Complex Field with Significant Potential for Future Treatments. Curr Rheumatol Rep 2021 Apr 28;23(6):41.
    doi: 10.1007/s11926-021-01007-9pubmed: 33913032google scholar: lookup
  17. Christmann U, Hancock CL, Poole CM, Emery AL, Poovey JR, Hagg C, Mattson EA, Scarborough JJ, Christopher JS, Dixon AT, Craney DJ, Wood PL. Dynamics of DHA and EPA supplementation: incorporation into equine plasma, synovial fluid, and surfactant glycerophosphocholines. Metabolomics 2021 Apr 17;17(5):41.
    doi: 10.1007/s11306-021-01792-5pubmed: 33866431google scholar: lookup